ReviewMaternal-fetal medicine (Wolters Kluwer Health, Inc.)2026
Postpartum Hemorrhage: A Comprehensive Review of Medical and Surgical Treatment.
Review in Maternal-fetal medicine (Wolters Kluwer Health, Inc.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Transradial access in interventional gynecology and obstetrics: Current evidence, clinical applications, and future directions.European journal of obstetrics & gynecology and reproductive biology: X · 2026Review
- Critical Appraisal of "Increased Incidence of Secondary PPH From Placental Site Subinvolution and Role of Interventional Radiology".Acute medicine & surgeryArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postpartum hemorrhage (PPH) is the leading cause of maternal morbidity and mortality worldwide. The incidence of PPH continues to rise. PPH is often responsive to both medical and surgical treatment. A stepwise multidisciplinary approach to PPH treatment has been shown to reduce maternal morbidity. Massive transfusion protocols are critical to any obstetrics unit. Intrauterine devices are often employed in the treatment of PPH. Placenta accreta spectrum greatly contributes to the PPH burden. Hysterectomy remains the definitive treatment of PPH; however, medical and surgical options are often successfully employed, avoiding the need for hysterectomy. Advances in interventional radiology have been shown to successfully treat PPH in the majority of cases. Clinical simulation has been shown to improve teamwork and outcomes in the treatment of PPH. Novel approaches to PPH show additional promise in reducing maternal morbidity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.